Wei Wang, M.D., Ph.D.

Peer-Reviewed Articles

1. Likki S, Lee K, Muhaj F, Wang W, Lin P, Cho WC, Ivan D, Torres-Cabala CA, Fayad L, Curry JL. Diffuse cutaneous ALK-immunoreactive histiocytosis with MEF2C::FLT3 fusion. JAAD Case Rep 65:233-236, 2025. e-Pub 2025. PMID: 41211348.
2. Medeiros LJ, Zhou J, Wang X, Wang W, Tang G, Hu S. Leukemic phase of MYC/BCL2 double-hit high-grade B-cell lymphoma: A report of 35 cases. Hum Pathol 164:105933, 2025. e-Pub 2025. PMID: 40925489.
3. Wang WJ, Hu Z, Gehris BT, Naik U, Bhattacharjee MB, Wahed MA, Hu S, You MJ, Chen L, Wang W, Medeiros LJ. Clinicopathological features of primary epidural B-cell lymphoma: a study of 14 cases. Pathology, 2025. e-Pub 2025. PMID: 41062339.
4. Bazinet A, Loghavi S, Wei Y, Bataller A, Sasaki K, Arani N, Darbaniyan F, Chien K, Hammond D, Bouligny I, Kanagal-Shamanna R, Thongon N, Tang G, Urrutia S, Kadia T, DiNardo C, Daver N, Short N, Issa G, Pemmaraju N, Jabbour E, Wang SA, Wang W, Borthakur G, Bueso-Ramos C, Ravandi F, Medeiros LJ, Kantarjian H, Garcia-Manero G, Montalban-Bravo G. Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy. Leukemia 39(9):2256-2265, 2025. e-Pub 2025. PMID: 40691503.
5. Khanlari M, Wang W, Tizro P, Eldomery MK. The immunophenotypic and genetic characterization of pediatric T -L ymphoblastic leukemia with a mature immunophenotype. Haematologica, 2025. e-Pub 2025. PMID: 40874330.
6. Wang WJ, Wang SA, Fang H, Wei Q, Jorgensen JL, Hu S, Xu J, Li S, Tang G, Tang Z, Medeiros LJ, Wang W. Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype. Cytometry B Clin Cytom, 2025. e-Pub 2025. PMID: 40814768.
7. Shen Q, Haddad FG, Jabbour EJ, Tang G, Fang H, Liu M, Hu AY, Wang W, Lin P, Issa GC, Kantarjian HM, Medeiros LJ, Hu S. Unusually Indolent CML: Absence of Complete Cytogenetic Response after 10 Years of Tyrosine Kinase Inhibitor Therapy. Clin Lymphoma Myeloma Leuk 25(8):e580-e590, 2025. e-Pub 2025. PMID: 40345959.
8. Wang W, Czader M, Wang SA. Blood- and bone marrow-based mature T-cell and natural killer cell leukemias and lymphomas: a summary in the series of the 2023 SH/EAHP Workshop. Am J Clin Pathol 164(1):7-25, 2025. e-Pub 2025. PMID: 40646680.
9. Croden J, Pemmaraju N, Fliehler K, Brown A, Wang W, Kantarjian H, Vega F, Kadia T. Managing BPDCN in the context of severe hyperbilirubinemia: a case study. Leuk Lymphoma:1-4, 2025. e-Pub 2025. PMID: 40569706.
10. Wang SA, Li S, Wang W, Xu J, Thakral B, Hu S, Ok CY, Jia F, Jorgensen JL, Medeiros LJ, Ravandi F, Short NJ, Loghavi S. Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort. Arch Pathol Lab Med, 2025. e-Pub 2025. PMID: 40522873.
11. E S, Medeiros LJ, Fang H, Li S, Tang G, Wang SA, Wang W, Yin CC, You MJ, Iyer SP, Malpica L, Qiu L, Tang Z, Wei Q, Lin P, Xu J. Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. Cancers (Basel) 17(11), 2025. e-Pub 2025. PMID: 40507248.
12. George GV, Kajstura M, Jajosky AN, Fang H, Jelloul FZ, Evans AG, Burack WR, Bennett JM, Medeiros LJ, Wang W, El Hussein S. Association Between B-Cell Marker Expression and RUNX1 Lesions in Acute Myeloid Leukemia, Beyond RUNX1::RUNX1T1 Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/Myeloid. Cancers (Basel) 17(8), 2025. e-Pub 2025. PMID: 40282530.
13. E S, Vega F, Khanlari M, Fang H, Xu J, Li S, Hu S, Wang SA, Wei Q, Wang WJ, Medeiros LJ, Wang W. BCL11B helps to define T-lineage in lymphomas/leukaemias with a mixed/ambiguous immunophenotype. Pathology, 2025. e-Pub 2025. PMID: 40318959.
14. E S, Jelloul FZ, Nahmod KA, Short N, Leventaki V, Jia F, Xu J, Loghavi S, Wang W, Jabbour LE, Tang G, Medeiros LJ, Wang SA. Acute lymphoblastic leukaemia with T- and B-lineage defining markers. Pathology, 2025. e-Pub 2025. PMID: 40318961.
15. Shen Q, Tang G, Haddad FG, Chen W, Wang WJ, Wang W, Wei Q, Medeiros LJ, Hu S. Unusually indolent CML: a stable non-responder without complete cytogenetic remission for 30 years including 17 years on tyrosine kinase inhibitor therapy. Leuk Lymphoma:1-4, 2025. e-Pub 2025. PMID: 39801075.
16. Kim DH, Medeiros LJ, Xu J, Tang G, Qiu L, Wang SA, Ok CY, Wang W, Yin CC, You MJ, Garces S, Lin P, Li S. Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Study of 60 Cases. Mod Pathol 38(5):100710, 2025. e-Pub 2025. PMID: 39805522.
17. Khanlari M, Wang W, Ni Y, Mead PE, Umeda M, Westover T, Ma J, Rubnitz JE, Barajas JM, Pounds S, Klco JM. Pediatric Myeloid Neoplasms With UBTF Tandem Duplications: Morphologic, Immunophenotypic, and Clinical Characterization. Am J Surg Pathol, 2025. e-Pub 2025. PMID: 39760616.
18. Sameeta F, Wang W, Jelloul FZ, Nwogbo OV, Thakral B, Xu J, Li S, Ok CY, Tang G, Jia F, Medeiros LJ, Loghavi S, Jorgensen JL, Wang SA. The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes. Arch Pathol Lab Med, 2024. e-Pub 2024. PMID: 39711284.
19. Nahmod KA, Miranda RN, Vega F, Thakral B, Pemmaraju N, Montalban-Bravo G, Loghavi S, Jelloul FZ, Wang W, Wang S, Muzzafar T, Patel K, Bueso-Ramos CE, Medeiros LJ, Kanagal-Shamanna R. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review. Leuk Lymphoma 66(4):1-9, 2024. e-Pub 2024. PMID: 39704386.
20. Fang H, Wang SA, Medeiros LJ, Wang W. Application of Flow Cytometry Immunophenotypic Analysis for the Diagnosis of Mature B-Cell Lymphomas/Leukemias. Hum Pathol:105711, 2024. e-Pub 2024. PMID: 39709144.
21. Fang H, Wang W, Medeiros LJ. Burkitt lymphoma. Hum Pathol:105703, 2024. e-Pub 2024. PMID: 39662784.
22. Jen WY, Sasaki K, Ravandi F, Kadia TM, Wang SA, Wang W, Loghavi S, Daver NG, DiNardo CD, Issa GC, Abbas HA, Nasnas C, Bataller A, Urrutia S, Karrar OS, Pierce SA, Kantarjian HM, Short NJ. Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy. Blood Adv 9(4):783-792, 2024. e-Pub 2024. PMID: 39631072.
23. Wei, Q, Hu, S, Xu, J, Loghavi, S, Daver, N, Toruner, GA, Wang, W, Medeiros, LJ, Tang, G. Detection of KMT2A Partial Tandem Duplication by Optical Genome Mapping in Myeloid Neoplasms. Cancers 16(24), 2024. e-Pub 2024. PMID: 39766092.
24. Wei Q, Fang H, Jing JM, Segura-Rivera R, Medeiros LJ, Wang W. Emergence of IGH::CCND1 rearrangement and mutations in TP53, BTK, and BCL2 associated with therapy resistance in chronic lymphocytic leukemia. EJHaem 5(6):1265-1268, 2024. e-Pub 2024. PMID: 39691246.
25. Sameeta F, Wang SA, Tang Z, Khoury JD, Fang H, Wang D, Xu J, Li S, Hu Z, Hu S, Jorgensen JL, Medeiros LJ, Wang W. Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. Am J Clin Pathol 162(5):455-463, 2024. e-Pub 2024. PMID: 38801226.
26. Marques-Piubelli ML, Kumar B, Basar R, Panowski S, Srinivasan S, Norwood K, Prashad S, Szenes V, Balakumaran A, Arandhya A, Lu W, Khan K, Duenas D, McAllen S, Gomez JA, Burks JK, Acharyal S, Borthakur G, Wang WL, Wang W, Wang S, Solis LM, Marin D, Rezvani K, Daher M, Vega F. Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents. Virchows Arch 485(5):937-941, 2024. e-Pub 2024. PMID: 38388965.
27. Tang Z, Wang W, Toruner GA, Hu S, Fang H, Xu J, You MJ, Medeiros LJ, Khoury JD, Tang G. Optical Genome Mapping for Detection of BCR::ABL1-Another Tool in Our Toolbox. Genes (Basel) 15(11), 2024. e-Pub 2024. PMID: 39596557.
28. George GV, Adlowitz DG, Okeson KR, Jelloul FZ, Fang H, Wang W, O'Malley DP, Medeiros LJ, El Hussein S. Cyclin-D1 rearrangement as a secondary event in the large cell transformation of splenic marginal zone lymphoma with a TP53 deletion. Virchows Arch, 2024. e-Pub 2024. PMID: 39432092.
29. Malik F, Eldomery MK, Wang W, Gheorghe G, Khanlari M. Myeloid sarcomas with CBFA2T3 : GLIS2 fusion: clinicopathologic characterization of 4 cases mimicking small round cell tumors. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 39418128.
30. Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, Toruner GA, Wang SA, Wang W, Miranda RN, Li S, Xu J, DiNardo CD, Daver N, Kadia TM, Issa GC, Kantarjian HM, Medeiros LJ, Tang G. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. Am J Hematol 99(10):1959-1968, 2024. e-Pub 2024. PMID: 39016111.
31. Xu J, Kim DH, Wang W, Li S, Lin P, Tang G, Konoplev S, Qiu L, Fang H, Garces S, Leventaki V, E S, Medeiros LJ, Wang SA. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. Am J Clin Pathol 163(2):240-250, 2024. e-Pub 2024. PMID: 39244687.
32. Sameeta F, Fang H, Wang W, Tang Z, Wang SA, Toruner GA, Parisi X, Khoury JD, Issa G, Garcia-Manero G, Medeiros LJ, Tang G, Loghavi S. Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma. Am J Hematol 99(9):1827-1829, 2024. e-Pub 2024. PMID: 38440855.
33. El Hussein S, Fang H, Jelloul FZ, Wang W, Loghavi S, Miranda RN, Friedberg JW, Burack WR, Evans AG, Xu J, Medeiros LJ. T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features. Arch Pathol Lab Med 148(8):914-920, 2024. e-Pub 2024. PMID: 38059511.
34. Bazinet A, Wang A, Li X, Jia F, Mo H, Wang W, Wang SA. Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence-assisted workflow. Cytometry B Clin Cytom 106(4):264-271, 2024. e-Pub 2024. PMID: 36824056.
35. Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 38946194.
36. Wang D, Fang H, Ok CY, Jorgensen JL, Medeiros LJ, Wang W, Wang SA. Advancing Diagnostic Accuracy and Quality of Patient Care Through the Implementation of a Flow Cytometry Quality Assurance Program. Arch Pathol Lab Med 149(2):e26-e30, 2024. e-Pub 2024. PMID: 38871355.
37. Nwogbo, OV, Fang, H, Wang, W, Xu, J, Miranda, R, Bose, P, Ok, CY, Jorgensen, JL, Medeiros, LJ, Wang, S. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis. American journal of clinical pathology 161(6):598-608, 2024. e-Pub 2024. PMID: 38372648.
38. Hu, S, Jabbour, EJ, Hu, CY, Tang, G, Wang, W, Medeiros, LJ, Bueso-Ramos, CE. Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge. American journal of hematology 99(4):721-726, 2024. e-Pub 2024. PMID: 38240333.
39. Yu, F, Wang, J, Ke, Z, Zhang, Y, Xu, L, Zhang, H, Huang, K, Cheng, F, Yang, H, Wang, L, Wang, Z, Shou, L, Yu, W, Fang, H, Medeiros, LJ, Wang, W. EBV-positive Nodal T-Cell and NK-Cell Lymphoma. American Journal of Surgical Pathology 48(4):406-416, 2024. e-Pub 2024. PMID: 38287746.
40. Wei Q, Wang SA, Loghavi S, Fang H, Medeiros LJ, Wang W. Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution. EJHaem 5(2):379-382, 2024. e-Pub 2024. PMID: 38633114.
41. Wang WJ, Gehris BT, Rivera D, Ak S, Feng D, Wang W, Hu Z. Bone marrow-restricted aberrant myeloperoxidase expression in B-acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia. EJHaem 5(2):403-407, 2024. e-Pub 2024. PMID: 38633116.
42. Khanlari M, Wang W, Liu YC, Wang L, Rubnitz JE, Dixon S, Orr BA, Anelo OM, Cheng Z, Balagopal V, Klco JM. Concurrent peripheral T-cell lymphoma and T-cell lymphoblastic leukemia/lymphoma with identical STIL::TAL1 fusion events. Haematologica 109(3):994-999, 2024. e-Pub 2024. PMID: 37767572.
43. Rivera, D, Cui, W, Gao, J, Peker, D, Zhang, Q, Dewar, R, Qiu, L, Konoplev, SN, Hu, Z, Sasaki, K, Hu, AY, E, S, Liu, M, Fang, H, Wang, W, Tang, G, Apperley, JF, Hochhaus, A, Cortes, JE, Khoury, J, Medeiros, LJ, Jabbour, EJ, Hu, S. Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: a Report From the BCR::ABL1 Pathology Group. Modern Pathology 37(2), 2024. e-Pub 2024. PMID: 38104892.
44. Rivera D, Naik U, Wang WJ, Cuglievan B, Yin CC, Chen L. Acute myeloid leukemia with inversion 16 and a novel PTPN11 mutation: A case report with literature review. Int J Lab Hematol 46(1):195-198, 2024. e-Pub 2024. PMID: 37872826.
45. Bataller A, Abuasab T, McCall D, Wang W, Cuglievan B, Issa GC, Jabbour E, Short N, DiNardo CD, Tang G, Garcia-Manero G, Kantarjian HM, Sasaki K. Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica 109(1):293-297, 2024. e-Pub 2024. PMID: 37646654.
46. Vanjari, N, Tang, G, Toruner, GA, Wang, W, Thakral, B, Zhao, M, Dave, BJ, Khoury, J, Medeiros, LJ, Tang, Z. Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review. Genes 14(12), 2023. e-Pub 2023. PMID: 38137010.
47. Qiu, L, Lin, P, Khanlari, M, Xu, J, Cohen, E, Garces, S, Miranda, RN, Wang, W, Fang, H, Bueso-Ramos, CE, Medeiros, LJ, Li, S. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Modern Pathology 36(12), 2023. e-Pub 2023. PMID: 37820764.
48. Wang, SA, Jorgensen, JL, Hu, S, Jia, F, Li, S, Loghavi, S, Ok, CY, Thakral, B, Xu, J, Medeiros, LJ, Wang, W. Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection. Cytometry Part B - Clinical Cytometry 104(5):356-366, 2023. e-Pub 2023. PMID: 37605812.
49. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. T-prolymphocytic leukemia. Leukemia 37(9):1919-1921, 2023. e-Pub 2023. PMID: 37443196.
50. Khanlari M, Wang L, Bolen CY, Otanez FSB, Furtado LV, Key L, Irwin L, Wang W, Klco JM. CBFA2T3::GLIS2-positive acute leukemia with RAM and mixed T/megakaryocytic phenotype. EJHaem 4(3):765-769, 2023. e-Pub 2023. PMID: 37601875.
51. Xue O, Curry CV, Fang H, Bueso-Ramos CE, Medeiros LJ, Wang W. Monocytic and blastic plasmacytoid dendritic cell differentiation in acute leukemia with KMT2A rearrangement. EJHaem 4(3):837-840, 2023. e-Pub 2023. PMID: 37601865.
52. Bazinet A, Kadia T, Short NJ, Borthakur G, Wang SA, Wang W, Loghavi S, Jorgensen J, Patel K, DiNardo C, Daver N, Alvarado Y, Haddad FG, Pierce S, Nogueras Gonzalez G, Maiti A, Sasaki K, Yilmaz M, Thompson P, Wierda W, Garcia-Manero G, Andreeff M, Jabbour E, Konopleva M, Huang X, Kantarjian H, Ravandi F. Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood Adv 7(13):3284-3296, 2023. e-Pub 2023. PMID: 36884300.
53. Li N, Lin P, Zuo Z, You MJ, Shuai W, Orlowski R, Manasanch EE, Li S, Xu J, Garces S, Jelloul FZ, Tang Z, Wang W, Medeiros LJ, Yin CC. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer Med 12(13):14293-14304, 2023. e-Pub 2023. PMID: 37212518.
54. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. DUSP22 rearrangement is associated with distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604-1615, 2023. e-Pub 2023. PMID: 36453104.
55. Jelloul FZ, Quesada AE, Yang RK, Li S, Wang W, Xu J, Tang G, Yin CC, Fang H, El Hussein S, Khoury J, Bassett RL, Garcia-Manero G, Manasanch EE, Orlowski RZ, Qazilbash MH, Patel KP, Medeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies. Mod Pathol 36(6):100166, 2023. e-Pub 2023. PMID: 36990279.
56. El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant. Virchows Arch 482(6):1011-1019, 2023. e-Pub 2023. PMID: 36864257.
57. Al-Jumaili Z, Helen Zhang Y, Wang WJ, Mai B, Wang XI, Ahmed A, Wang W, Hu S, James You M, Hu Z. High-Grade B-Cell Lymphoma With Malignant Effusions as the Initial Presentation. Am J Clin Pathol 159(5):420-428, 2023. e-Pub 2023. PMID: 36879405.
58. Hu Z, Medeiros LJ, Xu M, Yuan J, Peker D, Shao L, Tang Z, Mai B, Thakral B, Rios A, Hu S, Wang W. T-Cell Prolymphocytic Leukemia with t(X;14)(q28;q11.2). Am J Clin Pathol 159(4):325-336, 2023. e-Pub 2023. PMID: 36883805.
59. Xu J, Li S, Yin CC, Patel KP, Tang G, Wang W, Miranda RN, Garces S, Tang Z, Lin P, Medeiros LJ. Classic Hodgkin lymphoma with marked granulomatous reaction. Hum Pathol 134:114-123, 2023. e-Pub 2023. PMID: 36584716.
60. Shuai W, Zuo Z, Li N, Garces S, Jelloul FZ, Ok CY, Li S, Xu J, You MJ, Wang W, Rehder C, Jabbour EJ, Patel KP, Medeiros LJ, Yin CC. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129(6):878-889, 2023. e-Pub 2023. PMID: 36583229.
61. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B acute lymphoblastic leukemia/lymphoma. Haematologica 108(3):895-899, 2023. e-Pub 2023. PMID: 36325892.
62. Qiu L, Wang SA, Tang G, Wang W, Lin P, Xu J, Yin CC, Khanlari M, Medeiros LJ, Li S. Blastoid B-Cell Neoplasms. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765805.
63. Tang Z, Wang W, Yang S, El Achi H, Fang H, Nahmod KA, Toruner GA, Xu J, Thakral B, Ayoub E, Issa GC, Yin CC, You MJ, Miranda RN, Khoury JD, Medeiros LJ, Tang G. 3q26.2/MECOM Rearrangements by Pericentric Inv(3). Cancers (Basel) 15(2), 2023. e-Pub 2023. PMID: 36672407.
64. Yu F, Ba X, Yang H, Huang K, Zhang Y, Zhang H, Xu L, Wang J, Wang L, Wang Z, Fang H, Medeiros LJ, Wang W. Kikuchi disease with an exuberant proliferation of large T-cells. Histopathology 82(2):340-353, 2023. e-Pub 2023. PMID: 36221168.
65. Qiu L, Nwogbo OV, Medeiros LJ, Thakral B, Li S, Xu J, You MJ, Wang W, Quesada AE, Ramos CB, McDonnell TJ, Thomas SK, Lin P. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms. Hum Pathol 130:47-57, 2022. e-Pub 2022. PMID: 36244464.
66. Fang H, Khoury JD, Torres-Cabala CA, Ng SB, Xu J, El Hussein S, Hu S, Vega F, Li S, Tang Z, Tang G, Medeiros LJ, Wang W. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology 54(7):893-899, 2022. e-Pub 2022. PMID: 35864006.
67. Nahmod KA, Wang W, Saluja K, Tang Z, Medeiros LJ, Thakral B. B-lymphoblastic leukemia with Burkitt-like morphology and aberrant myeloperoxidase expression: A diagnostic conundrum. EJHaem 3(4):1406-1408, 2022. e-Pub 2022. PMID: 36467827.
68. Fang H, Wang SA, You MJ, Hu S, Miranda RN, Tang Z, Lin P, Jorgensen JL, Xu J, Thakral B, Schlette EJ, El Hussein S, Bueso-Ramos C, Medeiros LJ, Wang W. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors. Cytometry B Clin Cytom 102(6):440-447, 2022. e-Pub 2022. PMID: 36156384.
69. El Hussein S, Wang X, Fang H, Jelloul FZ, Wang W, Loghavi S, Vega F, Miranda RN, Muzzafar T, Manning JT, Khoury JD, Burack WR, Evans AG, Medeiros LJ. Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis. Am J Surg Pathol 46(9):1291-1297, 2022. e-Pub 2022. PMID: 35575765.
70. Wang L, Wang W, Beird HC, Cheng X, Fang H, Tang G, Toruner GA, Yin CC, You MJ, Issa GC, Borthakur G, Peng G, Khoury JD, Medeiros LJ, Tang Z. PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia. Genes (Basel) 13(8), 2022. e-Pub 2022. PMID: 36011278.
71. El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms. EJHaem 3(3):954-957, 2022. e-Pub 2022. PMID: 36051075.
72. Fang H, Toruner GA, Tang Z, Tang G, Weissferdt A, Tashakori M, El Hussein S, Thakral B, Quesada AE, Wang W, Patel KP, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE, Jelloul FZ. Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation. Ann Diagn Pathol 59:151951, 2022. e-Pub 2022. PMID: 35489185.
73. Wang W, Xu J, Khoury JD, Pemmaraju N, Fang H, Miranda RN, Yin CC, Hussein SE, Jia F, Tang Z, Hu S, Konopleva M, Medeiros LJ, Wang SA. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884435.
74. Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W. Acute promyelocytic leukemia. Cytometry B Clin Cytom 102(4):283-291, 2022. e-Pub 2022. PMID: 35716019.
75. Tashakori M, Wang W, Kadia TM, Daver NG, Montalban-Bravo G, Loghavi S, Wang SA, Medeiros LJ, Ravandi F, Khoury JD. Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy. Leuk Res 118:106860, 2022. e-Pub 2022. PMID: 35636055.
76. Khanlari M, Yin CC, Takahashi K, Lachowiez C, Tang G, Loghavi S, Bah I, Wang W, Konoplev S, Medeiros LJ, Pemmaraju N, Khoury JD, Wang SA. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36(5):1343-1350, 2022. e-Pub 2022. PMID: 35279700.
77. Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies. Cancer Genet 262-263:23-29, 2022. e-Pub 2022. PMID: 34974290.
78. Fang H, Wang W, Zhang L, Shen Q, Yuan J, Reichard KK, Hu Z, Medeiros LJ. Reactive Intralymphovascular Immunoblastic Proliferations Mimicking Aggressive Lymphomas. Am J Surg Pathol 46(3):326-335, 2022. e-Pub 2022. PMID: 34310368.
79. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow. Mod Pathol 35(3):419-426, 2022. e-Pub 2022. PMID: 34608246.
80. Konoplev S, Wang X, Tang G, Li S, Wang W, Xu J, Pierce SA, Jia F, Jorgensen JL, Ravandi F, Issa GC, Medeiros LJ, Wang SA. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults. Cytometry B Clin Cytom 102(2):123-133, 2022. e-Pub 2022. PMID: 34964255.
81. Liu H, Xu-Monette ZY, Tang G, Wang W, Kim Y, Yuan J, Li Y, Chen W, Li Y, Fedoriw GY, Zhu F, Fang X, Luedke C, Medeiros LJ, Young KH, Hu S. EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Histopathology 80(3):575-588, 2022. e-Pub 2022. PMID: 34637146.
82. Zhang Q, Kim DH, Xu Y, Wang W, Medeiros LJ. Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. Hum Pathol 119:105-113, 2022. e-Pub 2022. PMID: 34801601.
83. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
84. Jain N, Thompson P, Burger J, Ferrajoli A, Takahashi K, Estrov Z, Borthakur G, Bose P, Kadia T, Pemmaraju N, Sasaki K, Konopleva M, Jabbour E, Garg N, Wang X, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang S, Lopez W, Ayala A, Plunkett W, Gandhi V, Kantarjian H, O'Brien S, Keating M, Wierda WG. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35(12):3421-3429, 2021. e-Pub 2021. PMID: 34007049.
85. El Hussein S, Wang W, Wang SA, Fang H, Garces S, Tashakori M, Lyapichev KA, Qiu L, Wang X, Loghavi S, Medeiros LJ, Challagundla P, Jorgensen JL. Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens. Leuk Res 111:106704, 2021. e-Pub 2021. PMID: 34735934.
86. El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon. Leuk Lymphoma 62(13):1-4, 2021. e-Pub 2021. PMID: 34304666.
87. Yin CC, Pemmaraju N, You MJ, Li S, Xu J, Wang W, Tang Z, Alswailmi O, Bhalla KN, Qazilbash MH, Konopleva M, Khoury JD. Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 13(23), 2021. e-Pub 2021. PMID: 34884997.
88. Qiu L, Tang G, Li S, Wang W, Wang SA, Xu J. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor lymphoblastic leukemia. EJHaem 2(4):895-896, 2021. e-Pub 2021. PMID: 35845203.
89. Yang RK, Toruner GA, Wang W, Fang H, Issa GC, Wang L, Quesada AE, Thakral B, Patel KP, Peng G, Liu S, Yin CC, Borthakur G, Tang Z, Wang SA, Miranda RN, Khoury JD, Medeiros LJ, Tang G. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771519.
90. Abbas HA, Hao D, Tomczak K, Barrodia P, Im JS, Reville PK, Alaniz Z, Wang W, Wang R, Wang F, Al-Atrash G, Takahashi K, Ning J, Ding M, Beird HC, Mathews JT, Little L, Zhang J, Basu S, Konopleva M, Marques-Piubelli ML, Solis LM, Parra ER, Lu W, Tamegnon A, Garcia-Manero G, Green MR, Sharma P, Allison JP, Kornblau SM, Rai K, Wang L, Daver N, Futreal A. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nat Commun 12(1):6071, 2021. e-Pub 2021. PMID: 34663807.
91. Fang H, Wang W, El Hussein S, Morita K, Beird HC, Mitra A, Loghavi S, Lin P, Jabbour EJ, Khoury JD. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL. Br J Haematol 194(6):1034-1038, 2021. e-Pub 2021. PMID: 34402058.
92. Fang H, Wang W, Kadia TM, El Hussein S, Wang SA, Khoury JD. CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations. Leuk Res 108:106614, 2021. e-Pub 2021. PMID: 33990003.
93. Tang G, Tam W, Short NJ, Bose P, Wu D, Hurwitz SN, Bagg A, Rogers HJ, Hsi ED, Quesada AE, Wang W, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Nardi V, Hasserjian RP, Arber DA, Orazi A, Foucar K, Wang SA. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Mod Pathol 34(9):1673-1685, 2021. e-Pub 2021. PMID: 33990705.
94. Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol 7(8):1213-1219, 2021. e-Pub 2021. PMID: 34110383.
95. Xu N, Hao F, Dong X, Yao Y, Guan Y, Yang L, Chen F, Zheng F, Li Q, Liu W, Zhao C, Li W, Palavecino E, Wang W, Wang G. A two-transcript biomarker of host classifier genes for discrimination of bacterial from viral infection in acute febrile illness: a multicentre discovery and validation study. Lancet Digit Health 3(8):e507-e516, 2021. e-Pub 2021. PMID: 34325854.
96. Guan Y, Xu N, Yao Y, Zheng F, Chen F, Wang W, Dong X, Wang G. Subarachnoid hemorrhage secondary to Brucella-induced cerebral aneurysm: a case report. BMC Infect Dis 21(1):720, 2021. e-Pub 2021. PMID: 34332523.
97. Fang H, Wang SA, Xie W, Tang Z, Hu S, Krishnamurthy S, Medeiros LJ, Wang W. Clinicopathologic Features of Myelodysplastic Syndromes Involving Lymph Nodes. Am J Surg Pathol 45(7):930-938, 2021. e-Pub 2021. PMID: 33739784.
98. Weinberg OK, Chisholm KM, Ok CY, Fedoriw Y, Grzywacz B, Kurzer JH, Mason EF, Moser KA, Bhattacharya S, Xu M, Babu D, Foucar K, Tam W, Bagg A, Orazi A, George TI, Wang W, Wang SA, Arber DA, Hasserjian RP. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Mod Pathol, 2021. e-Pub 2021. PMID: 33526873.
99. Fang H, Yabe M, Zhang X, Kim Y, Wu X, Wei P, Chi S, Zheng L, Garcia-Manero G, Shao L, Yuan J, Shen Y, Zheng G, Tang G, Wang W, Loghavi S, Shen Q, Yuan Y, He R, Chen D, Medeiros LJ, Hu S. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases. Mod Pathol 34(6):1143-1152, 2021. e-Pub 2021. PMID: 33558656.
100. Cabrera TB, Wang W, Yedururi S, Slopis JM, Steiner RE, Rytting ME, Cuglievan B. Coincidental Expression of Classic Hodgkin Lymphoma and Neurofibromatosis Type I and Literature Review. J Pediatr Hematol Oncol 43(4):e535-e538, 2021. e-Pub 2021. PMID: 32366782.
101. Hu Z, Wang W, Thakral B, Chen Z, Estrov Z, Bueso-Ramos CE, Verstovsek S, Medeiros LJ, Wang SA. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution. Cytometry B Clin Cytom 100(3):352-360, 2021. e-Pub 2021. PMID: 32157815.
102. Wang W, Khoury JD, Miranda RN, Jorgensen JL, Xu J, Loghavi S, Li S, Pemmaraju N, Nguyen T, Medeiros LJ, Wang SA. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106(4):1047-1055, 2021. e-Pub 2021. PMID: 32241840.
103. Lyapichev KA, Bah I, Huen A, Duvic M, Routbort MJ, Wang W, Jorgensen JL, Medeiros LJ, Vega F, Craig FE, Wang SA. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry B Clin Cytom 100(2):183-191, 2021. e-Pub 2021. PMID: 32667737.
104. Hu Z, Pan Z, Chen W, Shi Y, Wang W, Yuan J, Wang E, Zhang S, Kurt H, Mai B, Zhang X, Liu H, Rios AA, Ma HY, Nguyen ND, Medeiros LJ, Hu S. Primary Effusion Lymphoma: A Clinicopathological Study of 70 Cases. Cancers (Basel) 13(4), 2021. e-Pub 2021. PMID: 33669719.
105. Fang H, Chuang HH, Strati P, Hu S, Shuai W, Medeiros LJ, Wang W. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic Findings. Am J Surg Pathol 45(2):160-168, 2021. e-Pub 2021. PMID: 32769427.
106. Fang H, Medeiros LJ, Tang Z, Wang W, Ok CY, Patel KP, Khoury JD, Thakral B. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later. Ann Diagn Pathol 50:151649, 2021. e-Pub 2021. PMID: 33189964.
107. Ronaghy A, Hu S, Tang Z, Wang W, Tang G, Loghavi S, Li S, Thakral B, Medeiros LJ, Muzzafar T. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities. Mod Pathol 34(2):300-313, 2021. e-Pub 2021. PMID: 33110238.
108. Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, Rausch CR, McClain KL, Rao KV, Popat UR, Fayad LE, Champa N, Calvo KR, Allen CE, Kadia TM, Pemmaraju N. Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol 192(3):667-671, 2021. e-Pub 2021. PMID: 33238033.
109. Li Y, Yang W, Wang W, Lin D, Wei H, Wang Y, Liu B, Wang H, Xiao J, Ru Y, Dong S, Wang J, Mi Y. Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases. Leuk Res Rep 15:100236, 2021. e-Pub 2021. PMID: 33665079.
110. Gu J, Wang W, Tang G, Toruner GA, Zhao M, Sfamenos S, Tang Z, Khoury JD, Medeiros LJ. Donor Cell-Derived Acute Myeloid Leukaemia with 3q26.2 Involvement/MECOM Rearrangement ‐ A Case Report and Literature Review. OBM Transplantation 4(4):11, 2020. e-Pub 2020.
111. Shao H, Wang W, Song J, Tang G, Zhang X, Tang Z, Srivastava J, Shah B, Medeiros LJ, Zhang L. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement. Leuk Res 99:106460, 2020. e-Pub 2020. PMID: 33166908.
112. Vega F, Amador C, Chadburn A, Feldman AL, Hsi ED, Wang W, Medeiros LJ. American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms. Ann Diagn Pathol 49:151623, 2020. e-Pub 2020. PMID: 32947231.
113. Mai B, Wang W, Lin M, Hu S, Wang XI, Chen L, Wahed A, Nguyen A, Ma HY, Medeiros LJ, Hu Z. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients. AIDS 34(12):1735-1743, 2020. e-Pub 2020. PMID: 32889849.
114. Tang Z, Toruner GA, Tang G, Cameron Yin C, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol, 2020. e-Pub 2020. PMID: 32404952.
115. Wang W, Thakral B. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia?. Blood 136(13):1565, 2020. e-Pub 2020. PMID: 32970810.
116. Wang W, Beird H, Kroll CJ, Hu S, Bueso-Ramos CE, Fang H, Tang G, Tang Z, Wang F, Takahashi K, You MJ, Khoury JD, Medeiros LJ, Futreal PA. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid. Leukemia, 2020. e-Pub 2020. PMID: 32099038.
117. Shuai W, Lin P, Strati P, Patel KP, Routbort MJ, Hu S, Wei P, Khoury JD, You MJ, Loghavi S, Tang Z, Fang H, Thakral B, Medeiros LJ, Wang W. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features. Blood Cancer J 10(8):86, 2020. e-Pub 2020. PMID: 32848129.
118. Tang Z, Chen H, Hong L, Tang G, Toruner GA, Wang W, Roy Chowdhuri S, Yin W, Jung HS, Gu J, Routbort MJ, Zhang J, Khoury JD, Medeiros LJ. Inconsistent Intersample ALK FISH Results in Patients with Lung Cancer: Analysis of Potential Causes. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32674491.
119. Xie W, Xu J, Hu S, Li S, Wang W, Cameron Yin C, Toruner G, Tang Z, Jeffrey Medeiros L, Tang G. iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome. Mod Pathol 33(7):1389-1397, 2020. e-Pub 2020. PMID: 32034282.
120. Fang H, Tang G, Loghavi S, Greipp P, Wang W, Verstovsek S, Medeiros LJ, Reichard KK, Miranda RN, Wang SA. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms. Histopathology 76(7):1042-1054, 2020. e-Pub 2020. PMID: 32083752.
121. Liu W, Thakral B, Tang G, Wang W, Medeiros LJ, Konoplev S. From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion. Ann Diagn Pathol 46:151514, 2020. e-Pub 2020. PMID: 32330662.
122. Gong Z, Zhou T, Liu H, Tang G, Yin CC, Wang W, Medeiros LJ, Hu S. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia. Br J Haematol 189(5):e207-e211, 2020. e-Pub 2020. PMID: 32237084.
123. Li HF, Xing BP, Song LS, Wang W, Liu BH. Successful rescue using tracheal intubation cannula for severe central airway stenosis after tracheotomy: A CARE compliant case report. Medicine (Baltimore) 99(21):e20117, 2020. e-Pub 2020. PMID: 32481279.
124. Xiu Y, Dong Q, Fu L, Bossler A, Tang X, Boyce B, Borcherding N, Leidinger M, Sardina JL, Xue HH, Li Q, Feldman A, Aifantis I, Boccalatte F, Wang L, Jin M, Khoury J, Wang W, Hu S, Yuan Y, Wang E, Yuan J, Janz S, Colgan J, Habelhah H, Waldschmidt T, Müschen M, Bagg A, Darbro B, Zhao C. Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion. Blood 135(2):108-120, 2020. e-Pub 2020. PMID: 31697816.
125. Xu N, Wang W, Chen F, Li W, Wang G. ELISA is superior to bacterial culture and agglutination test in the diagnosis of brucellosis in an endemic area in China. BMC Infect Dis 20(1):11, 2020. e-Pub 2020. PMID: 31906870.
126. Gu, J, Wang, W, Tang, G, Toruner, GA, Zhao, M, Sfamenos, S, Tang, Z, Khoury, J, Medeiros, LJ. Donor Cell-Derived Acute Myeloid Leukaemia with 3q26.2 Involvement/MECOM Rearrangement ‐ A Case Report and Literature Review. OBM Transplantation 4(4), 2020. e-Pub 2020.
127. Chen Z, Ok CY, Wang W, Goswami M, Tang G, Routbort M, Jorgensen JL, Medeiros LJ, Wang SA. Low-Grade Myelodysplastic Syndromes With Preserved CD34+ B-Cell Precursors (CD34+ Hematogones). Cytometry B Clin Cytom, 2020. e-Pub 2020. PMID: 31211490.
128. El Achi H, Glass WF, Wang W, Medeiros LJ, Hu Z. Reactive lymphadenopathy with concurrent idiopathic plasma cell variant Castleman disease, amyloid deposition and non-caseating granulomas. Pathology 51(7):762-764, 2019. e-Pub 2019. PMID: 31662201.
129. Mai B, Wang W, Medeiros LJ, Ma HY, Hu Z. TdT-positive high grade B-cell lymphoma transformed from grade 3B follicular lymphoma in an HIV-positive patient. Pathology 51(7):764-768, 2019. e-Pub 2019. PMID: 31666176.
130. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol, 2019. e-Pub 2019. PMID: 31261288.
131. Gong Z, Xu ML, Chen M, Cui W, Kantarjian HM, Cortes JE, Zhou T, Tang G, Wang W, Medeiros LJ, Hu S. Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia. Am J Hematol, 2019. e-Pub 2019. PMID: 31273842.
132. Wang W, Medeiros LJ. Utility of Cyclin D1 in the Diagnostic Workup of Hematopoietic Neoplasms: What Can Cyclin D1 Do for Us?. Adv Anat Pathol 26(5):281-291, 2019. e-Pub 2019. PMID: 31261248.
133. Zhong B, Medeiros LJ, Wang W. The emergence of a JAK2 V617F-mutated clone in myelodysplastic syndrome is associated with disease progression and features of myelofibrosis. Br J Haematol 186(3):396, 2019. e-Pub 2019. PMID: 31134612.
134. Tang, Z, Tang, G, Hu, S, Patel, KP, Yin, CC, Wang, W, Lin, P, Toruner, GA, Ok, CY, Gu, J, Lu, X, Khoury, J, Medeiros, LJ. Data on MECOM rearrangement-driven chromosomal aberrations in myeloid malignancies. Data in Brief 24, 2019. e-Pub 2019. PMID: 31193989.
135. Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P. Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia. Pathology 51(3):340-343, 2019. e-Pub 2019. PMID: 30846229.
136. Tang Z, Tang G, Hu S, Patel KP, Yin CC, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Medeiros LJ. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations. Cancer Genet 233-234:21-31, 2019. e-Pub 2019. PMID: 31109591.
137. Hu Z, Ramos CB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P. Utility of JAK2 V617F allelic burden in distinguishing chronic Myelomonocytic leukemia from primary myelofibrosis with Monocytosis. Hum Pathol, 2019. e-Pub 2019. PMID: 30447300.
138. Angelova EA, Li S, Wang W, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P. IgM plasma cell myeloma in the era of novel therapy: a Clinicopathologic study of 17 cases. Hum Pathol, 2019. e-Pub 2019. PMID: 30266252.
139. Wang W, Medeiros LJ, Lin P. Plasma Cell Leukemia Presents with Marked Plasmacytosis and TP53 Mutation. Hematopathology, 2019. e-Pub 2019.
140. Li C, Huang L, Lu H, Wang W, Chen G, Gu Y, Zhou Q, Peng Z, Feng Z. Expression and clinical significance of ubiquitin-specific-processing protease 34 in diffuse large B-cell lymphoma. Mol Med Rep 18(5):4543-4554, 2018. e-Pub 2018. PMID: 30221700.
141. Angelova EA, Medeiros LJ, Wang W, Muzzafar T, Lu X, Khoury JD, Ravandi F, Patel KP, Hu Z, Kanagal-Shamanna R. Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience. Mod Pathol 31(11):1717-1732, 2018. e-Pub 2018. PMID: 29955146.
142. Hidalgo-L?pez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value. Cancer 124(19):3849-3855, 2018. e-Pub 2018. PMID: 30321462.
143. Wu H, Liu B, Li B, Wang Y, Wang H, Medeiros LJ, Zhang B, Wang W. Granular B-acute lymphoblastic leukemia: Ultrastructural characterization of cytoplasmic granules. Leuk Res 73:105-107, 2018. e-Pub 2018. PMID: 30268960.
144. Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 73:86-94, 2018. e-Pub 2018. PMID: 30248580.
145. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol 31(9):1470-1478, 2018. e-Pub 2018. PMID: 29785017.
146. Kurt H, Zheng L, Kantarjian HM, Tang G, Ravandi-Kashani F, Garcia-Manero G, Gong Z, Amin HM, Konoplev SN, Routbort MJ, Han X, Wang W, Medeiros LJ, Hu S. Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome. Mod Pathol 31(7):1141-1154, 2018. e-Pub 2018. PMID: 29449681.
147. Wang W, Routbort MJ, Loghavi S, Tang Z, Medeiros LJ, Wang SA. Characterization of chronic myelomonocytic leukemia with TP53 mutations. Leuk Res 70:97-99, 2018. e-Pub 2018. PMID: 29908419.
148. Ye H, Desai A, Gong T, Zeng D, Nomie K, Chen W, Wang W, Romaguera J, Wang ML. Spontaneous regression of mantle cell lymphoma: a report of four cases. Cancer Commun (Lond) 38(1):30, 2018. e-Pub 2018. PMID: 29843782.
149. Wang W, Kanagal-Shamanna R, Medeiros JL. Lymphoproliferative Disorders with Concurrent HHV8 and EBV Infection: Beyond Primary Effusion Lymphoma and Germinotropic Lymphoproliferative Disorder. Histopathology, 2018. e-Pub 2018. PMID: 29105119.
150. Gong Z, Wang W, Hu S. Cytogenetic alterations in CML: not all created equal. Oncotarget 9(15):11885-11886, 2018. e-Pub 2018. PMID: 29552278.
151. Jaitly V, Wang W. B-cell acute lymphoblastic leukemia in JAK2 V617F-positive polycythemia vera. Blood 131(8):941, 2018. e-Pub 2018. PMID: 29472375.
152. Tang Z, Zhang J, Lu X, Wang W, Chen H, Robinson MK, Cheng J, Tang G, Medeiros LJ. Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma. Mod Pathol, 2018. e-Pub 2018. PMID: 28914263.
153. Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W. 3q26/EVI1 Rearrangement in Myelodysplastic/Myeloproliferative Neoplasms: an Early Event Associated with a Poor Prognosis. Leuk Res 65:25-28, 2018. e-Pub 2018. PMID: 29288910.
154. Gong Z, Medeiros LJ, Cortes JE, Chen Z, Zheng L, Li Y, Bai S, Lin P, Miranda RN, Jorgensen JL, McDonnell TJ, Wang W, Kantarjian HM, Hu S. Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy. Blood Adv 1(26):2541-2552, 2017. e-Pub 2017. PMID: 29296906.
155. Hu Z, Sun Y, Wang W, Medeiros LJ, Kanagal-Shamanna R. Refractory Hairy Cell Leukemia-Variant. Am J Hematol, 2017. e-Pub 2017. PMID: 27727469.
156. Wang W, Routbort MJ, Tang Z, Ok CY, Patel KP, Daver N, Garcia-Manero G, Medeiros LJ, Wang SA. Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype. Eur J Haematol, 2017. e-Pub 2017. PMID: 28926144.
157. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol, 2017. e-Pub 2017. PMID: 28776574.
158. Wang W, Wang S, Medeiros LJ, Khoury JD. Response to Dr. Bain's comment on our review article: Pure Erythroid Leukemia. Am J Hematol, 2017. e-Pub 2017. PMID: 28707397.
159. Wang W, Routbort MJ, Ok CY, Patel KP, Sun Y, Kanagal-Shamanna R, Medeiros LJ, Wang SA. Characterization of TP53 mutations in clonal cytopenia of undetermined significance. Am J Hematol 92(8):E175-E177, 2017. e-Pub 2017. PMID: 28494520.
160. Pina-Oviedo S, Wang W, Vicknair E, Manning JT, Medeiros LJ. Follicular lymphoma with hyaline-vascular Castleman disease-like follicles and CD20 positive follicular dendritic cells. Pathology 49(5):544-547, 2017. e-Pub 2017. PMID: 28689633.
161. Gong Z, Medeiros LJ, Cortes JE, Zheng L, Khoury JD, Wang W, Tang G, Loghavi S, Luthra R, Yang W, Kantarjian HM, Hu S. Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia. Blood Cancer J 7(7):e583, 2017. e-Pub 2017. PMID: 28708130.
162. Hu Z, Medeiros LJ, Wang W, Chen Z, Tang G, Hodjat P, Yang S, Fang L, Li Y, Verstovsek S, Hu S. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms. Mod Pathol 30(7):940-951, 2017. e-Pub 2017. PMID: 28338652.
163. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol 65:147-156, 2017. e-Pub 2017. PMID: 28551329.
164. Salem A, Loghavi S, Tang G, Huh YO, Jabbour EJ, Kantarjian H, Wang W, Hu S, Luthra R, Medeiros LJ, Khoury JD. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm. Am J Hematol, 2017. e-Pub 2017. PMID: 28253536.
165. Gong Z, Xie W, Wang W, Chen Z, Xu J, Yuan J, Zhou Y, Wang D, Medeiros LJ, Hu S. T-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy: a report of 14 cases. Int J Lab Hematol, 2017. e-Pub 2017. PMID: 27863007.
166. Chen Z, Shao C, Wang W, Zuo Z, Mou X, Hu SJ, DiGiuseppe JA, Zu Y, Medeiros LJ, Hu S. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia, 2017. e-Pub 2017. PMID: 27560111.
167. Gong Z, Zheng L, Tang Z, Chen Z, Wang W, Bai S, Tang G, Jeffrey Medeiros L, Hu S. Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Ann Hematol, 2017. e-Pub 2017. PMID: 27915425.
168. Chen Z, Medeiros LJ, Kantajian HM, Zheng L, Gong Z, Patel KP, Xiong H, Wang W, Cortes JE, Hu S. Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia. Blood Cancer J 7(2):e521, 2017. e-Pub 2017. PMID: 28157214.
169. Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, Lu X, Pham LV, Young KH, Wang W, Hu S. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients. Am J Surg Pathol, 2017. e-Pub 2017. PMID: 27776009.
170. Miao Y, Hu S, Lu X, D SL, Wang W, Medeiros LJ, Lin P. Double-hit Follicular Lymphoma with MYC and BCL2 Translocations: A Study of 7 Cases with a Review of Literature. Hum Pathol, 2016. e-Pub 2016. PMID: 27544800.
171. Miao Y, Lin P, Wang W, Jeffrey Medeiros L, Lu X. CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma. Am J Clin Pathol 146(6):747-752, 2016. e-Pub 2016. PMID: 28028120.
172. Wang W, Chen Z, Hu Z, Yin CC, Li S, Bai S, Bueso-Ramos CE, Medeiros LJ, Hu S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer J 6(11):e490, 2016. e-Pub 2016. PMID: 27813536.
173. Messer A, Jenkinson H, Wang W, Duvic M. New B-cell Lymphomas in the Setting of a Previous Rare Breast Implant-Associated B-cell Lymphoma. Plast Reconstr Surg Glob Open 4(11):e1148, 2016. e-Pub 2016. PMID: 27975038.
174. Masarova L, Wang W, Newberry KJ, Kantarjian H, Verstovsek S. Complete hematologic, histomorphologic, cytogenetic, and molecular remission in a patient with JAK2- and IDH2-positive myelofibrosis. Blood, 2016. e-Pub 2016. PMID: 27325105.
175. Jain P, Verstovsek S, Wang W, Loghavi S, Torres HA, Estrov Z, Patel KP, Pemmaraju N. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia. Leuk Lymphoma 57(8):1969-73, 2016. e-Pub 2016. PMID: 26700872.
176. Quesada AE, Huh YO, Wang W, Medeiros LJ, Thakral B. Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis. Pathology 48(5):513-5, 2016. e-Pub 2016. PMID: 27311871.
177. Chen Z, Cortes JE, Jorgensen JL, Wang W, Yin CC, You MJ, Jabbour E, Kantarjian HM, Medeiros LJ, Hu S. Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia 30(7):1606-9, 2016. e-Pub 2016. PMID: 26837843.
178. Wang W, Cortes JE, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127(22):2742-50, 2016. e-Pub 2016. PMID: 27006386.
179. Fang L, Hu Y, Wang W, Hu S, Zhang LI, Wang R. Development of multiple malignancies following long-term glucocorticoid therapy in a patient with leukocytoclastic vasculitis: A case report. Mol Clin Oncol 4(6):929-932, 2016. e-Pub 2016. PMID: 27284425.
180. Wang W, Tang G, Kadia T, Lu X, Li Y, Huang L, Montenegro-Garreaud X, Miranda RN, Wang SA. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. J Natl Compr Canc Netw 14(6):708-11, 2016. e-Pub 2016. PMID: 27283163.
181. Chen Z, Wang W, Cortes JE, Liu E, Miranda RN, Zhao C, Yuan J, Lu X, Yang W, Ameri MD, Kantarjian HM, Medeiros LJ, Hu S. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood Cancer J 6:e418, 2016. e-Pub 2016. PMID: 27152845.
182. Wang W, Ali S, Tang Z, Miranda RN, Yang S, Medeiros LJ, Hu S. Constitutional pericentric inversion of chromosome 9 has no impact on survival in chronic myelogenous leukemia. Ann Hematol 95(4):657-9, 2016. e-Pub 2016. PMID: 26758271.
183. Tang Z, Medeiros LJ, Yin CC, Wang W, Lu X, Young KH, Khoury JD, Tang G. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists. Mol Cytogenet 9:62, 2016. e-Pub 2016. PMID: 27508005.
184. Khandakar B, Wang W, Li S. Primary splenic red pulp diffuse large B-cell lymphoma with anaplastic features. Stem Cell Investig 3:9, 2016. e-Pub 2016. PMID: 27358901.
185. Chen Z, Wang W, Verstovsek S, Cortes JE, Medeiros LJ, Hu S. Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm. Int J Lab Hematol 37(6):e150-2, 2015. e-Pub 2015. PMID: 26086872.
186. Zhou X, Zhang J, Yun H, Shi R, Wang Y, Wang W, Lagercrantz SB, Mu K. Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration. Oncotarget 6(34):36894-902, 2015. e-Pub 2015. PMID: 26384297.
187. Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z, Tang G, Jorgensen JL, Medeiros LJ, Hu S. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia 29(11):2263-6, 2015. e-Pub 2015. PMID: 25931274.
188. Liu H, Wang W, Tang G, Yin CC, Muzzafar T, Medeiros LJ, Hu S. Lymphomatous variant of hairy cell leukaemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology 67(5):740-5, 2015. e-Pub 2015. PMID: 25809821.
189. Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM, McDonnell TJ, Ok CY, Kantarjian HM, Medeiros LJ, Hu S. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood 126(14):1699-706, 2015. e-Pub 2015. PMID: 26243778.
190. Wang W, Xie W, Hu S. Cup-like blasts in B-lymphoblastic leukaemia. Br J Haematol 170(5):596, 2015. e-Pub 2015. PMID: 26132718.
191. Chen Z, Wang W, Rich A, Tang G, Hu S. Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases. Am J Hematol 90(8):E146-8, 2015. e-Pub 2015. PMID: 25960187.
192. Wang W, Hu S, Lu X, Young KH, Medeiros LJ. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases. Am J Surg Pathol 39(8):1132-9, 2015. e-Pub 2015. PMID: 25828391.
193. Wang W, Hu S. Neoplastic plasma cells mimic mature neutrophils in plasma cell myeloma with t(11;14)(q13;q32). Blood 125(18):2875, 2015. e-Pub 2015. PMID: 26120642.
194. Jaitly V, Wang W, Hu S. Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia. Stem Cell Investig 2:13, 2015. e-Pub 2015. PMID: 27358881.
195. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8:32, 2015. e-Pub 2015. PMID: 25888368.
196. Wang W, Deng Z, Hatcher H, Miller LD, Di X, Tesfay L, Sui G, D'Agostino RB, Torti FM, Torti SV. IRP2 regulates breast tumor growth. Cancer Res 74(2):497-507, 2014. e-Pub 2014. PMID: 24285726.
197. Wang, W, Pardee, TS, Beaty, MW. Subcutaneous panniculitis-like T cell lymphoma with mesenteric involvement. Journal of Hematopathology 6(3):155-159, 2013. e-Pub 2013.
198. Wang W, Grier DD, Woo J, Ward M, Sui G, Torti SV, Torti FM, Beaty MW. Ferritin H is a novel marker of early erythroid precursors and macrophages. Histopathology 62(6):931-40, 2013. e-Pub 2013. PMID: 23611361.
199. Wang W, Pardee TS, Beaty MW. Subcutaneous panniculitis-like T-cell lymphoma with mesenteric involvement. Journal of Hematopathology 6(3):155-159, 2012. e-Pub 2012.
200. Wan M, Huang W, Kute TE, Miller LD, Zhang Q, Hatcher H, Wang J, Stovall DB, Russell GB, Cao PD, Deng Z, Wang W, Zhang Q, Lei M, Torti SV, Akman SA, Sui G. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. Am J Pathol 180(5):2120-33, 2012. e-Pub 2012. PMID: 22440256.
201. Persad P, Manavi C, Beaty M, Wang W, Pettenati MJ. idic(7)(q11.2). Atlas Genet Cytogenet Oncol Haematol 16(9):676-676, 2012. e-Pub 2012.
202. Wang W, Manavi C, Pang C, Koty P, Pettenati MJ. +7 or trisomy 7 (solely). Atlas Genet Cytogenet Oncol Haematol 16(9):674-675, 2012. e-Pub 2012.
203. Han J, Seaman WE, Di X, Wang W, Willingham M, Torti FM, Torti SV. Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS One 6(8):e23800, 2011. e-Pub 2011. PMID: 21886823.
204. Pinnix ZK, Miller LD, Wang W, D'Agostino R, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2(43):43ra56, 2010. e-Pub 2010. PMID: 20686179.
205. Wang W, Di X, Torti SV, Torti FM. Ferritin H induction by histone deacetylase inhibitors. Biochem Pharmacol 80(3):316-24, 2010. e-Pub 2010. PMID: 20385107.
206. Jiao Y, Wilkinson J, Di X, Wang W, Hatcher H, Kock ND, D'Agostino R, Knovich MA, Torti FM, Torti SV. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 113(2):462-9, 2009. e-Pub 2009. PMID: 18815282.
207. Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 283(49):33911-8, 2008. e-Pub 2008. PMID: 18819919.
208. dos Santos CO, Dore LC, Valentine E, Shelat SG, Hardison RC, Ghosh M, Wang W, Eisenstein RS, Costa FF, Weiss MJ. An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA. J Biol Chem 283(40):26956-64, 2008. e-Pub 2008. PMID: 18676996.
209. Blish KR, Wang W, Willingham MC, Du W, Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D'Agostino RB, Torti FM, Torti SV. A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol Biol Cell 19(2):457-64, 2008. e-Pub 2008. PMID: 18032587.
210. Wang W, Di X, D'Agostino RB, Torti SV, Torti FM. Excess capacity of the iron regulatory protein system. J Biol Chem 282(34):24650-9, 2007. e-Pub 2007. PMID: 17604281.
211. Jiao Y, Wilkinson J, Christine Pietsch E, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation in the biological activity of curcumin. Free Radic Biol Med 40(7):1152-60, 2006. e-Pub 2006. PMID: 16545682.

Review Articles

1. Xia C, Liu G, Liu J, Ronaghy A, Tadros S, Wang W, Fang H, Zhang S, Khoury JD, Tang Z. The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications. Genes (Basel) 16(3), 2025. e-Pub 2025. PMID: 40149404.
2. El Hussein S, Wang W. Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms. Cancers (Basel) 16(11), 2024. e-Pub 2024. PMID: 38893237.
3. El Hussein S, Evans AG, Fang H, Wang W, Medeiros LJ. Unicentric Castleman Disease: Illustration of Its Morphologic Spectrum and Review of the Differential Diagnosis. Arch Pathol Lab Med 148(1):99-106, 2024. e-Pub 2024. PMID: 36920021.
4. Rivera D, Wang WJ, Chan KH, Ali H, Wang W, Medeiros LJ, Hu Z. From the archives of MD Anderson Cancer Center Castleman disease involving the thymus gland. Ann Diagn Pathol 65:152136, 2023. e-Pub 2023. PMID: 37060884.
5. Alotaibi F, Thakral B, Wang W, Medeiros LJ. From the archives of MD Anderson Cancer Center. Ann Diagn Pathol 63:152084, 2023. e-Pub 2023. PMID: 36577188.
6. El Hussein S, Wang W. Plasmacytoid dendritic cells in the setting of myeloid neoplasms. Br J Haematol 200(5):545-555, 2023. e-Pub 2023. PMID: 36606610.
7. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours. Leukemia 36(7):1703-1719, 2022. e-Pub 2022. PMID: 35732831.
8. El Hussein S, Medeiros LJ, Hu S, Lin P, Wang W. The many faces of plasma cell neoplasms. Pathology 54(1):32-42, 2022. e-Pub 2022. PMID: 34887091.
9. Wang W, Zhang Q, Medeiros LJ. Syncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant. Hum Pathol 117:115-125, 2021. e-Pub 2021. PMID: 34058246.
10. Wang X, Wang W, Vega F, Quesada AE. Aggressive Mediastinal Lymphomas. Semin Diagn Pathol 41(3):125-139, 2021. e-Pub 2021. PMID: 34175178.
11. Wang W, Lin P. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis. Pathology 52(1):6-14, 2020. e-Pub 2020. PMID: 31767130.
12. Wang, W, Medeiros, LJ. Castleman Disease. Surgical Pathology Clinics 12(3):849-863, 2019. e-Pub 2019. PMID: 30991840.
13. Wang W, Medeiros LJ. Castleman Disease. Surg Pathol Clin 12(3):849-863, 2019. e-Pub 2019. PMID: 31352991.
14. Sanz-De Pedro M, Wang W, Kanagal-Shamanna R, Khoury JD. Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria. Curr Hematol Malig Rep 13(6):467-476, 2018. e-Pub 2018. PMID: 30338456.
15. Boddu P, Benton CB, Wang W, Borthakur G, Khoury JD, Pemmaraju N. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev, 2018. e-Pub 2018. PMID: 28965757.
16. Wang W, Wang SA, Medeiros LJ, Khoury JD. Pure erythroid leukemia. Am J Hematol 92(3):292-296, 2017. e-Pub 2017. PMID: 28006859.
17. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochim Biophys Acta 1800(8):760-9, 2010. e-Pub 2010. PMID: 20304033.

Editorials

1. Wang W, Khoury JD. Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go. Cytometry B Clin Cytom 104(1):12-14, 2023. PMID: 36573832.

Abstracts

1. Chen Z, Wang W, Medeiros J, Hu S. Differential Impact of Additional Chromosomal Abnormalities in Myeloid and Lymphoid Blast Phase of Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors. USCAP 105th Annual Meeting, 2016. e-Pub 2016.
2. Xie W, Wang W, Ji Y, Zhou Y, Medeiros LJ, Hu S. T-Lymphoblastic Blast Crisis of Chronic Myelogenous Leukemia: A Study of 11 Cases. USCAP 105th Annual Meeting, 2016. e-Pub 2016.
3. Hu Z, Wang W, Chen Z, Tang G, Lu X, Li S, Medeiros LJ, Hu S. Mantle Cell Lymphoma with MYC Rearrangement: Best Considered as a Form of Double Hit Lymphoma?. USCAP 105th Annual Meeting, 2016. e-Pub 2016.
4. Wang W, Cortes J, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian H, Medeiros LJ, Hu S. Risk Stratification of Additional Chromosomal Changes in Chronic Myelogenous Leukemia in Era of Tyrosine Kinase Inhibitor Therapy. USCAP 105th Annual Meeting, 2016. e-Pub 2016.
5. Rich A, Ai D, Wang W, You MJ, Yin CC, Bueso-Ramos CE, Medeiros LJ, Hu S. Pediatric Chronic Myelogenous Leukemia in Tyrosine Kinase Inhibitor Era. USCAP 104th Annual Meeting, 2015. e-Pub 2015.
6. Wang W, Cortes J, Lin P, Beaty M, Ai D, Amin HM, McDonnell TJ, Kantarjian HM, Medeiros LJ, Hu S. Clinical and prognostic significance of 3q26 rearrangements and other chromosome 3 abnormalities in chronic myelogenous leukemia in era of tyrosine kinase inhibitors. Society of Hematologic Oncology annual meeting, 2015. e-Pub 2015.
7. Wang W, Ai D, Tang G, Liu H, Bueso-Ramos CE, Medeiros LJ, Hu S. Balanced 11q23/MLL Rearrangement in Chronic Myelogenous Leukemia. USCAP 104th Annual Meeting, 2015. e-Pub 2015.
8. Wang W, Hu S, Lu X, Young KH, Medeiros LJ. Triple-Hit B-Cell Lymphomas with MYC, BCL2 and BCL6 Translocations: Morphological, Immunophenotypical, and Clinical Features. USCAP 104th Annual Meeting, 2015. e-Pub 2015.
9. Wang W, Cortes J, Lin P, Khoury J, Zhenya DA, Guilin T, Jorgensen J, Medeiros LJ, Hu S. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in era of tyrosine kinase inhibitors. Society of Hematologic Oncology annual meeting, 2015. e-Pub 2015.
10. Wang W, Bergman S, Hurd D, Zamkoff K, Beaty MW. Large granular lymphocytic leukemia after allogeneic hematopoietic stem cell transplant. USCAP 103rd Annual Meeting, 2014. e-Pub 2014.
11. JKSS P, Wang W, Beaty M, Pang C. Evaluation of SOX11 in Acute Leukemias of Ambiguous Lineage in Comparison to Acute Myeloid and Lymphoblastic Leukemias. USCAP 103rd Annual Meeting, 2014. e-Pub 2014.
12. Wang W, Manavi C, and Grier D. Acute leukemia with t(9;11)(p22;q23): presented with myeloid sarcoma and relapsed as acute lymphoblastic leukemia. The Society for Hematopathology and European Association for Haematopathology Workshop, 2013. e-Pub 2013.
13. Wang W, Torti FM, Torti SV, and Beaty MW. Ferritin H is a novel marker of tumor-associated macrophages and its expression is associated with tumor grade. 102nd United States & Canadian Academy of Pathology (USCAP) annual meeting, 2013. e-Pub 2013.
14. Wang W, Holley C, Pettenati M, Grier D, and Beaty MW. Acute myeloid leukemia with t(9;22)(q34;q11.2), favor therapy-related. The Society for Hematopathology and European Association for Haematopathology Workshop, 2013. e-Pub 2013.
15. Wang W, Pettenati M, and Pang C. B lymphoblastic leukemia with t(5;14)(q31;q32). The Society for Hematopathology and European Association for Haematopathology Workshop, 2013. e-Pub 2013.
16. Wang W, Holley C, Pettenati M, Grier D, and Beaty MW. Acute promyelocytic leukemia with PML-RARA rearrangement, FISH negative. The Society for Hematopathology and European Association for Haematopathology Workshop, 2013. e-Pub 2013.
17. Wang W, Deng Z, Torti SV, Torti FM. The mechanisms of IRP2 overexpression in breast cancer. College of American Pathologists Annual Meeting, 2012. e-Pub 2012.
18. Wang W, Pardee TS, and Beaty MW. Subcutaneous panniculitis-like T-cell lymphoma with mesenteric involvement. XVI Meeting of the European Association for Haematopathology, 2012. e-Pub 2012.
19. Wang W, Pang CS. Peripheral T-cell lymphoma with aberrant expression of CD20 and CD79a. XVI Meeting of the European Association for Haematopathology, 2012. e-Pub 2012.
20. Wang W, Torti SV, Torti FM, and Beaty MW. Ferritin H is a maker of erythroid precursors in bone marrow biopsy specimens. XVI Meeting of the European Association for Haematopathology, 2012. e-Pub 2012.
21. Wang W, Grier D, Woo J, Beaty A, MW. Ferritin H is a novel marker of macrophages. American Society for Clinical Pathology (ASCP), 2012. e-Pub 2012.

Book Chapters

1. Wang W, Haferlach T. Acute erythroid leukemia. In: WHO Classification of Haematolymphoid Tumors, 2023.
2. Cross N, Padron E, Haferlach C, Wang W. Chronic eosinophilic leukemia. In: WHO Classification of Haematolymphoid Tumors, 2023.
3. Wang W, Medeiros LJ. HHV8-associated lymphoproliferative disorders. In: Practical Lymph Node and Bone Marrow Pathology: Frequently Asked Questions. Springer International, 2019.
4. Wang W, You J. Acute myeloid leukemia, acute panmyelosis with myelofibrosis subtype. In: Case Studies in Hematology and Coagulation. ASCP Press, 2018.

Letters to the Editor

1. Wang WJ, Shen Q, Tashakori M, Fang H, Shuai W, Lin P, Zhang Z, Tang G, Wang W, Linden MA, Jabbour EJ, Kadia TM, Short NJ, Daver NG, Medeiros LJ, Hu S. Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes. Am J Hematol, 2025.
2. Azevedo, RS, Wang, S, Swanson, DM, Daver, N, Pemmaraju, N, Kadia, TM, Issa, GC, Yilmaz, M, Borthakur, G, Senapati, J, Jen, WY, Short, NJ, Ravandi-Kashani, F, Wang, W, Fang, H, Xu, J, Patel, KP, Tang, G, Medeiros, LJ, DiNardo, C, Loghavi, S. CD123 expression and its correlation with mutation profile in acute myeloid leukaemia. British Journal of Haematology 207: 1648-1652, 2025.
3. Zhou, T, Curry, CV, Khanlari, M, Shi, M, Cui, W, Peker, D, Chen, W, Wang, E, Gao, J, Shen, Q, Xie, W, Jelloul, FZ, King, RL, Yuan, J, Wang, X, Zhao, C, Obiorah, IE, Courville, E, Nomura, E, Cherian, S, Xu, ML, Burack, WR, Liu, Hx, Jabbour, EJ, Takahashi, K, Wang, W, Wang, SA, Khoury, J, Medeiros, LJ, Hu, S. Genetics and pathologic landscape of lineage switch of acute leukemia during therapy. Blood cancer journal 14, 2024.
4. Dimopoulos YP, Wang W, Wang SA, Loghavi S, DiNardo CD, Gerstein Y, Hu S, Tang Z, Ilagan CJL, Thakral B, El Hussein S, Xu J, Li S, Lin P, Patel KP, Ok CY, Medeiros LJ, Fang H. The spectrum of hematologic neoplasms in patients with Li-Fraumeni syndrome. Am J Hematol 99: 2416-2419, 2024.
5. Hu Z, Yin CC, Sun X, Han X, Wang W, Wang S, You MJ. A diagnostic dilemma for a patient with skin lesions and marked leukocytosis: mixed-phenotype acute leukaemia or blastic plasmacytoid dendritic cell neoplasm with aberrant cytoplasmic CD3 expression?. Pathology, 2024.
6. Shen Q, Jabbour EJ, Tang G, Fang H, Wang W, Short NJ, You MJ, Medeiros LJ, Hu S. Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia. Am J Hematol 99: 2244-2248, 2024.
7. E S, Nahmod KA, Thakral B, Wang W, Jorgensen JL, Wang SA. CD133 in T-lymphoblastic leukemia is preferentially expressed in early T-phenotype (ETP) and near ETP subtypes. Cytometry B Clin Cytom, 2024.
8. Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Lin P, Konopleva M, You MJ, Miranda RN, Wang X, Wei Q, Medeiros LJ, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica 109: 2711-2715, 2024.
9. Dong, Q, Wang, Y, Xiu, Y, Wu, X, O'Neill, S, Meyerson, HJ, Tobias, S, Moriggl, R, Hu, S, Wang, W, Zhao, C. Unveiling myeloid transformation: T-LGLL with eosinophilia masking myeloid-associated STAT5B mutation culminating in AML. British Journal of Haematology 204: 2487-2491, 2024.
10. Gehris BT, Wang WJ, Mai B, Chen L, Wang W, Hu Z. Initial classic Hodgkin lymphoma and subsequent diffuse large B-cell lymphoma. Pathology 56: 115-118, 2024.
11. Fang, H, Medeiros, LJ, Wang, W. Acute myeloid leukemia with mutated TP53. American journal of hematology 98: E354-E355, 2023.
12. Fang H, Wang SA, Khoury JD, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Kadia T, Medeiros LJ, Wang W. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica 107: 2232-2237, 2022.
13. Wang X, Tang G, Hu Z, Fang H, Wang W, Tang Z, Toruner GA, Zhou T, DiNardo CD, Garcia-Manero G, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Hu S. Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival. Br J Haematol 198: 604-608, 2022.
14. Ghosh A, Chen L, Wahed A, Wang W, Saluja K, Nguyen AND, Hu S, Hu Z. Incidental but rapidly progressing T-cell prolymphocytic leukemia with t(X;14)(q28;q11) involving parotid lymphoepithelial cysts. Int J Lab Hematol 44: e17-e20, 2022.